Person
1 episodes · 5 quoted claims
Teresa Carlson says CitiBlock, a General Catalyst-backed company serving underserved patients, is paid only when patients get better, under a value and outcomes-based model.
“they literally do not get paid until the patient gets better. So it's a value outcomes-based model”
Teresa Carlson argues that the FDA should lead healthcare AI policy rather than creating broad new regulation.
“The FDA has been doing their job a long time. Let's let them actually work toward what the right policy is for their environment for healthcare.”
Teresa Carlson says venture capital invested about $11 billion in healthcare AI in the year of the episode, within a health market of about four to five trillion dollars.
“venture capital is investing, I think, alone, about 11 billion this year in AI technology for healthcare.”
Teresa Carlson says Hippocratic AI, a General Catalyst investment, aims to close the healthcare worker shortage by helping staff scale.
“their mission is really to close the growing shortage of healthcare workers by helping them scale.”
Teresa Carlson says Hippocratic AI uses an AI agent that phones patients to ask follow-up questions, without prescribing or acting as a doctor.
“there's an agentic AI that calls the patient and says, ask them questions about their health.”